News | August 08, 2025
IOL Chemicals post Q1 FY26 consolidated profit at Rs. 33.93 Cr
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
The company expects meaningful revenue contribution from this long-term agreement
The CDMO upgrade represents a transformational step for Remedium Lifecare
Subscribe To Our Newsletter & Stay Updated
